Menu Search
Equities

So-Young International Inc

SY:NMQ

So-Young International Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.736
  • Today's Change-0.053 / -6.69%
  • Shares traded92.00
  • 1 Year change-29.90%
  • Beta0.8989
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy3
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in CNY

The 3 analysts offering 12 month price targets for So-Young International Inc - ADR have a median target of 1.51, with a high estimate of 1.51 and a low estimate of 1.31. The median estimate represents a 105.31% increase from the last price of 0.736.
High105.3%1.51
Med105.3%1.51
Low77.8%1.31

Earnings history & estimates in CNY

On Aug 23, 2024, So-Young International Inc - ADR reported 2nd quarter 2024 earnings of 0.21 per share. This result was in line with the expectation of the one analyst following the company and exceeded last year's 2nd quarter results by 40.00%.
The next earnings announcement is expected on Nov 19, 2024.
Average growth rate+68.77%
So-Young International Inc - ADR reported annual 2023 earnings of 0.57 per share on Mar 20, 2024.
Average growth rate-9.71%
More ▼

Revenue history & estimates in CNY

So-Young International Inc. had 2nd quarter 2024 revenues of 407.38m. This bettered the 386.99m estimate of the one analyst covering the company. This was 25.29% above the prior year's 2nd quarter results.
Average growth rate+1.10%
So-Young International Inc. had revenues for the full year 2023 of 1.50bn. This was 19.09% above the prior year's results.
Average growth rate+9.14%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.